Property | Value |
Name | Uterine leiomyomata a clinical study |
Description | Clinical study:- Verma Madhurima1, Gupta Ritu 2, Porwal Sanjay K3*, Swarnkar Madhusudan 4 & Porwal Varsha5 1Assistant Professor,2Associate Professor, Department of Obstetrics and Gynaecology, 3Associate Professor, Department of General Surgery,4Assistant Professor, Department of community Medicine, 5Senior Demonstrator, Department of Anatomy, Jhalawar Hospital and Medical College Society, Jhalawar (Rajasthan)- India.
Abstract:- Background: Uterine leiomyoma is a common entity in premenopausal women. Only a subset of women is symptomatic and needs surgical treatment. Objective: To evaluate the clinical presentation, socio-demography, management outcome and its determinants in Rajasthan, India. Methods: This study was carried out at SMS Medical College Jaipur Rajasthan, a tertiary care hospital in Jaipur Rajasthan. Retrospective review of case records of all surgically managed cases of uterine leiomyoma over a period of 18 month done. Five hundred and eight women with uterine leiomyoma seen and managed surgically in Gynaecology Department. Results: Incidence of leiomyoma was 6.8% of gynaecological admission. The commonest presenting complaints were menstrual disorder (60.4%), abdominal pain (44.6%), abdominal lump (6.2%) and infertility (2.1%). The average uterine size at presentation was 6-8weeks (20.4%). The maximum number of cases 406(79.9%) were in age group of 31-50 years. Total abdominal hysterectomy done in (94.8%) cases. Conclusion: Uterine fibroid are commonly seen in premenopausal women and commonly present with menstrual disorders and may be associated with pelvic pain, infertility, pressure symptoms etc. The uterine size range from nonpalpable to 22 weeks pregnancy size. The treatment is abdominal hysterecetomy and myomectomy.
Keywords:- Uterine Leiomyomata, Menstrual disorder, Hysterectomy.
References:- 1. Parker WH. Uterine myomas: management. Fertility and Sterility. 2007;88(2):255–71. 2. Buttran VCJR, Reiter RC. Uterine fibromyomata- etiology, symptomatology and management. Fertility and Sterility. 1981; 4:36–41. 3. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308:1589–92. 4. Evans P, Brunsell S. Uterine fibroid tumours: Diagnosis and treatment. American Family Physcian.2007;75:1503–18. 5. Anate M. Uterine fibroids in Federal medical Centre, Lokoja: a five year review 2002–2006. The Nigerian Clinical Review Journal. 2007 Jan-Feb: 5–12. 6. Ogunniyi SO, Fasubaa OB. Uterine Fibromyoma in Ilesha, Nigeria. Nigerian Medical Practioner.1990;19(6):93–5. 7. Emembolu JO. Uterine fibromyomata; presentation and management in Northern Nigeria.International Journal of Gynecology and Obstetrics. 1987;25:413–6. 8. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American Journal of Obstetrics and Gynaecology 2003;188:100–7. 9. Vollenhoven BJ, Lawerence AS, Healy DL. Uterine fibroids: a clinical review. British Journal of Obstetrics and Gynaecology 1990;97:285–98. 10.Omu AE, Ihejerika IJ, Tabowei G. Management of uterine fibroids at UBTH. Tropical Doctor.1984;14:82–5. 11. Briggs ND. Common gynaecological tumours. Tropical Journal of Obstetrics and Gynaecology.1995;12(12):62–71. 12. Lurie S, Piper I, Woliovitch I, Glezerman M. Age- related prevalence of sonographically confirmed uterine myomas. Journal of obstetrics and Gynaecology. 2005;25:42–4. 13. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas) American Family Physcian.2005;71:1753–6. 14. Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Human Reproduction.2004;49:2350–5. 15. Sengupta BS, Wynter HM, Matachial L, Halfen A. Myomectomy in infertile Jamaican women Fat. J Gynaecology and Obstetrics. 1978;15:397–402. 16. Rackow BW, Arici A. Fibroids and in-vitro fertilization: which comes first? Current Opinion in Obstetrics and Gynecology. 2005;17:225–31. 17. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Human Reproduction Update.2000;6:614–20. 18. Witherspoon JT. The hormonal origin of uterine fibroid: a hypothesis. American Journal of Cancer.1935;24:402–6. 19. Ezem BU, Otubu JA. Hysterectomy in the Hausa/Fulani population in Nigeria. International journal of Gynecology and Obstetrics. 1981;19:145–7. 20. Cooper NP, Okolo S. Fibroids in pregnancy-common but poorly understood. Obstetric and Gynecological Survey. 2005; 60:132–8. 21. Jonas HS, Masterdon BJ. Giant uterine tumours: case report and review of literature. Obstetrics and Gynecology. 1972;50:25–9. 22. Omu AE, Ehiegiegba EA. Myomectomy: a reappraisal of postoperative performance. Asia and Oceania Journal of Obstetrics and Gynaecology. 1983;9(1):43–8. 23. Akinola OI, Ottun TA, Fabanwo RO, Akinniyi OA. Blateral uterine artery ligation: an effective low technology option in the management of symptomatic uterine fibroids. Tropical Journal of Obstetrics and Gynaecology. 2003;20:4–6. 24. Uterine leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome. Afr Health Sci.2011 June;11(2):271-8. PMCID: PMC 31585150 25. Fibroids and infertility, An updated systemic review and evidence, Pritts E A; fertile steril; 2009-91;1215-23.
Copyright © 2013 Porwal Sanjay K et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
Filename | Porwal Sanjay K et al.(672-676).pdf |
Filesize | 101.91 kB |
Filetype | pdf (Mime Type: application/pdf) |
Creator | admin |
Created On: | 03/05/2013 00:00 |
Viewers | Everybody |
Maintained by | Editor |
Hits | 3493 Hits |
Last updated on | 04/04/2013 06:40 |
Homepage | |
CRC Checksum | |
MD5 Checksum |